Recent studies have reported that the observed decrease in the expression of GTPBP4 could inhibit the proliferation of human colon cancer cells, while its increased expression was related to a decreased survival rate in colon and breast cancer patients (Andrea et al., 2010; Yu et al., 2016). Here, GTPBP4 is linked to breast cancer.